Welcome!

News Feed Item

Traumatic Spinal Cord Injury Global Clinical Trials Review, H2, 2014

LONDON, Aug. 25, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

Traumatic Spinal Cord Injury Global Clinical Trials Review, H2, 2014

https://www.reportbuyer.com/product/2312346/Traumatic-Spinal-Cord-Injury-Global-Clinical-Trials-Review-H2-2014.html

Traumatic Spinal Cord Injury Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, "Traumatic Spinal Cord Injury Global Clinical Trials Review, H2, 2014" provides data on the Traumatic Spinal Cord Injury clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Traumatic Spinal Cord Injury. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Traumatic Spinal Cord Injury. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6

Traumatic Spinal Cord Injury 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Countries: Proportion of Traumatic Spinal Cord Injury to Central Nervous System Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Traumatic Spinal Cord Injury to Central Nervous System Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Unaccomplished Trials of Traumatic Spinal Cord Injury 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Traumatic Spinal Cord Injury Therapeutics Clinical Trials 26
Prominent Drugs 27
Clinical Trial Profiles 28
Clinical Trial Overview of Top Companies 28
Stem Cell Sciences UK Ltd 28

Clinical Trial Overview of Stem Cell Sciences UK Ltd 28
NuVasive, Inc. 29
Clinical Trial Overview of NuVasive, Inc. 29
AOSpine International 30
Clinical Trial Overview of AOSpine International 30
Acorda Therapeutics, Inc. 31
Clinical Trial Overview of Acorda Therapeutics, Inc. 31
Clinical Trial Overview of Top Institutes / Government 32
Simon Fraser University 32
Clinical Trial Overview of Simon Fraser University 32
Tehran University of Medical Sciences 33
Clinical Trial Overview of Tehran University of Medical Sciences 33
Shanghai Changzheng Hospital 34
Clinical Trial Overview of Shanghai Changzheng Hospital 34
Christian Medical College 35
Clinical Trial Overview of Christian Medical College 35
Indian Council of Medical Research 36
Clinical Trial Overview of Indian Council of Medical Research 36
Rennes University Hospital 37
Clinical Trial Overview of Rennes University Hospital 37
Yonsei University 38
Clinical Trial Overview of Yonsei University 38
Capital District Health Authority, Canada 39
Clinical Trial Overview of Capital District Health Authority, Canada 39
Hadassah Medical Organization 40
Clinical Trial Overview of Hadassah Medical Organization 40
University of Miami 41
Clinical Trial Overview of University of Miami 41
Five Key Clinical Profiles 42
Appendix 56
Abbreviations 56
Definitions 56
Research Methodology 57
Secondary Research 57
About GlobalData 58
Contact Us 58
Disclaimer 58
Source 58

List of Tables
Traumatic Spinal Cord Injury Therapeutics, Global, Clinical Trials by Region, 2014* 7
Traumatic Spinal Cord Injury Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Traumatic Spinal Cord Injury Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 10
Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Europe, Top Countries, 2014* 11
Traumatic Spinal Cord Injury Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Proportion of Traumatic Spinal Cord Injury to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 14
Traumatic Spinal Cord Injury Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Traumatic Spinal Cord Injury Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Traumatic Spinal Cord Injury to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 17
Traumatic Spinal Cord Injury Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Traumatic Spinal Cord Injury Therapeutics, Global, Clinical Trials by Phase, 2014* 19
Traumatic Spinal Cord Injury Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 20
Traumatic Spinal Cord Injury Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Traumatic Spinal Cord Injury Therapeutics, Global, Terminated Clinical Trials, 2014* 22
Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Traumatic Spinal Cord Injury Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 24
Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 25
Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 26

Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 27
Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Stem Cell Sciences UK Ltd, 2014* 28
Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by NuVasive, Inc., 2014* 29
Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by AOSpine International, 2014* 30
Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Acorda Therapeutics, Inc., 2014* 31
Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Simon Fraser University, 2014* 32
Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2014* 33
Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Shanghai Changzheng Hospital, 2014* 34
Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Christian Medical College, 2014* 35
Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Indian Council of Medical Research, 2014* 36
Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Rennes University Hospital, 2014* 37
Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Yonsei University, 2014* 38
Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Capital District Health Authority, Canada, 2014* 39
Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Hadassah Medical Organization, 2014* 40
Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Miami, 2014* 41

List of Figures
Traumatic Spinal Cord Injury Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Traumatic Spinal Cord Injury Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Traumatic Spinal Cord Injury Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 10
Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Europe, Top Countries (%), 2014* 11
Traumatic Spinal Cord Injury Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Proportion of Traumatic Spinal Cord Injury to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 14
Traumatic Spinal Cord Injury Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Traumatic Spinal Cord Injury Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Traumatic Spinal Cord Injury to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 17
Traumatic Spinal Cord Injury Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Traumatic Spinal Cord Injury Therapeutics, Global, Clinical Trials by Phase (%), 2014* 19
Traumatic Spinal Cord Injury Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 20
Traumatic Spinal Cord Injury Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Traumatic Spinal Cord Injury Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 24
Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 25
Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 26
Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 27
GlobalData Methodology 57

Read the full report:
Traumatic Spinal Cord Injury Global Clinical Trials Review, H2, 2014

https://www.reportbuyer.com/product/2312346/Traumatic-Spinal-Cord-Injury-Global-Clinical-Trials-Review-H2-2014.html

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]  
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Transformation Abstract Encryption and privacy in the cloud is a daunting yet essential task for both security practitioners and application developers, especially as applications continue moving to the cloud at an exponential rate. What are some best practices and processes for enterprises to follow that balance both security and ease of use requirements? What technologies are available to empower enterprises with code, data and key protection from cloud providers, system administrators, inside...
Digital Transformation: Preparing Cloud & IoT Security for the Age of Artificial Intelligence. As automation and artificial intelligence (AI) power solution development and delivery, many businesses need to build backend cloud capabilities. Well-poised organizations, marketing smart devices with AI and BlockChain capabilities prepare to refine compliance and regulatory capabilities in 2018. Volumes of health, financial, technical and privacy data, along with tightening compliance requirements by...
@DevOpsSummit at Cloud Expo, taking place November 12-13 in New York City, NY, is co-located with 22nd international CloudEXPO | first international DXWorldEXPO and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. The widespread success of cloud computing is driving the DevOps revolution in enterprise IT. Now as never before, development teams must communicate and collaborate in a dynamic, 24/7/365 environment. There is no time t...
DXWorldEXPO LLC announced today that "IoT Now" was named media sponsor of CloudEXPO | DXWorldEXPO 2018 New York, which will take place on November 11-13, 2018 in New York City, NY. IoT Now explores the evolving opportunities and challenges facing CSPs, and it passes on some lessons learned from those who have taken the first steps in next-gen IoT services.
Containers and Kubernetes allow for code portability across on-premise VMs, bare metal, or multiple cloud provider environments. Yet, despite this portability promise, developers may include configuration and application definitions that constrain or even eliminate application portability. In this session we'll describe best practices for "configuration as code" in a Kubernetes environment. We will demonstrate how a properly constructed containerized app can be deployed to both Amazon and Azure ...
SYS-CON Events announced today that Silicon India has been named “Media Sponsor” of SYS-CON's 21st International Cloud Expo, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Published in Silicon Valley, Silicon India magazine is the premiere platform for CIOs to discuss their innovative enterprise solutions and allows IT vendors to learn about new solutions that can help grow their business.
SYS-CON Events announced today that CrowdReviews.com has been named “Media Sponsor” of SYS-CON's 22nd International Cloud Expo, which will take place on June 5–7, 2018, at the Javits Center in New York City, NY. CrowdReviews.com is a transparent online platform for determining which products and services are the best based on the opinion of the crowd. The crowd consists of Internet users that have experienced products and services first-hand and have an interest in letting other potential buye...
In his general session at 19th Cloud Expo, Manish Dixit, VP of Product and Engineering at Dice, discussed how Dice leverages data insights and tools to help both tech professionals and recruiters better understand how skills relate to each other and which skills are in high demand using interactive visualizations and salary indicator tools to maximize earning potential. Manish Dixit is VP of Product and Engineering at Dice. As the leader of the Product, Engineering and Data Sciences team at D...
In this presentation, you will learn first hand what works and what doesn't while architecting and deploying OpenStack. Some of the topics will include:- best practices for creating repeatable deployments of OpenStack- multi-site considerations- how to customize OpenStack to integrate with your existing systems and security best practices.
Modern software design has fundamentally changed how we manage applications, causing many to turn to containers as the new virtual machine for resource management. As container adoption grows beyond stateless applications to stateful workloads, the need for persistent storage is foundational - something customers routinely cite as a top pain point. In his session at @DevOpsSummit at 21st Cloud Expo, Bill Borsari, Head of Systems Engineering at Datera, explored how organizations can reap the bene...
We are seeing a major migration of enterprises applications to the cloud. As cloud and business use of real time applications accelerate, legacy networks are no longer able to architecturally support cloud adoption and deliver the performance and security required by highly distributed enterprises. These outdated solutions have become more costly and complicated to implement, install, manage, and maintain.SD-WAN offers unlimited capabilities for accessing the benefits of the cloud and Internet. ...
"IBM is really all in on blockchain. We take a look at sort of the history of blockchain ledger technologies. It started out with bitcoin, Ethereum, and IBM evaluated these particular blockchain technologies and found they were anonymous and permissionless and that many companies were looking for permissioned blockchain," stated René Bostic, Technical VP of the IBM Cloud Unit in North America, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Conventi...
In his session at 20th Cloud Expo, Scott Davis, CTO of Embotics, discussed how automation can provide the dynamic management required to cost-effectively deliver microservices and container solutions at scale. He also discussed how flexible automation is the key to effectively bridging and seamlessly coordinating both IT and developer needs for component orchestration across disparate clouds – an increasingly important requirement at today’s multi-cloud enterprise.
You want to start your DevOps journey but where do you begin? Do you say DevOps loudly 5 times while looking in the mirror and it suddenly appears? Do you hire someone? Do you upskill your existing team? Here are some tips to help support your DevOps transformation. Conor Delanbanque has been involved with building & scaling teams in the DevOps space globally. He is the Head of DevOps Practice at MThree Consulting, a global technology consultancy. Conor founded the Future of DevOps Thought Leade...
Security, data privacy, reliability and regulatory compliance are critical factors when evaluating whether to move business applications from in-house client hosted environments to a cloud platform. In her session at 18th Cloud Expo, Vandana Viswanathan, Associate Director at Cognizant, In this session, will provide an orientation to the five stages required to implement a cloud hosted solution validation strategy.